Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE (ASPIRE)
Drug-Related Side Effects and Adverse Reactions
About this trial
This is an interventional other trial for Drug-Related Side Effects and Adverse Reactions focused on measuring Older patients, Inappropriate prescribing, Clinical pharmacy
Eligibility Criteria
Inclusion Criteria:
- Patients admitted to one of the study wards under supervision of a geriatrician
- A written informed consent by the patient or his/her representative
- Discharged from the hospital
Exclusion Criteria:
- Admitted for a maximum of one day
- Unable to understand Dutch
- Being in a palliative stage as stated in their medical record with active withdrawal of drug therapy
- Patients being discharged to another ward within the same hospital or to another hospital
Sites / Locations
- University Hospitals LeuvenRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Usual care group
Intervention group
No pharmacist will be actively involved in the medication review, counseling or discharge and post-discharge procedure. In both groups the best possible preadmission drug list will be compiled for inpatients within 72 hours after admission to the geriatric ward. If potentially dangerous or life-threatening drug errors are observed in the usual care group, this will be communicated to the treating physician
The clinical pharmacist-collaborative service in the intervention group comprises six steps based on the clinical pharmacy intervention proposal of Van der Linden et al (Drugs Aging 2020). The first three steps focus on optimizing the drug therapy of geriatric inpatients. The remaining steps target a safe transition from the hospital to the community.